Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice

Journal of Neuroimmunology

Volumn 206, Issue 1-2, 2009, Pages 58-69

  Lu, Zhengqi ^a   Hu, Xueqiang ^a   Zhu, Cansheng ^a   Wang, Dunjing ^a   Zheng, Xueping ^a   Liu, Quentin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Ciliary neurotrophic factor; Experimental autoimmune encephalomyelitis; Mesenchymal stem cells; Multiple sclerosis

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; C57BL 6 MOUSE; CYTOKINE PRODUCTION; DEMYELINATION; FEMALE; FUNCTION TEST; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IMMUNOREGULATION; MESENCHYMAL STEM CELL; MOUSE; MULTIPLE SCLEROSIS; MYELINATION; NERVE CELL; NERVE FUNCTION; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; AMINO ACIDS; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS; CASPASE 3; CELL COUNT; CILIARY NEUROTROPHIC FACTOR; CYTOKINES; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENETIC VECTORS; GLYCOPROTEINS; GREEN FLUORESCENT PROTEINS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PROTEOGLYCANS; RECOVERY OF FUNCTION; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 58149267685     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.10.014     Document Type: Article

References (40)

1. Albrecht P.J., Dahl J.P., Stoltzfus O.K., Levenson R., and Levison S.W. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp. Neurol. 173 (2002) 46-62
2. Albrecht P.J., Enterline J.C., Cromer J., and Levison S.W. CNTF-activated astrocytes release a soluble trophic activity for oligodendrocyte progenitors. Neurochem. Res. 32 (2007) 263-271
3. Arakawa Y., Sendtner M., and Thoenen H. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture comparison with other neurotrophic factors and cytokines. J. Neurosci. 10 (1990) 3507-3515
4. Arnason B.G. Treatment of multiple sclerosis with interferon beta. Biomed. Pharmacother. 53 (1999) 344-350
5. Arnon R., and Aharoni R. Mechanism of action of glatiramer ace tate in multiple sclerosis and its potential for the development of new applications. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14593-14598
6. Bacigalupo A., and Palandri F. Management of acute graft versus host disease (GvHD). Hematol. J. 5 (2004) 189-196
7. Barres B.A., Hart I.K., Coles H.S., Burne J.F., Voyvodic J.T., Richardson W.D., and Raff M.C. Cell death in the oligodendrocyte lineage. J. Neurobiol. 23 (1992) 1221-1230
8. Bjartmar C., Kidd G., Mörk S., Rudick R., and Trapp B.D. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann. Neurol. 48 (2000) 893-901
9. Chen Q., Long Y., Yuan X., Zou L., Sun J., Chen S., Perez-Polo J.R., and Yang K. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J. Neurosci. Res. 80 (2005) 611-619
10. Clatterbuck R., Price D., and Koliatsos V. Ciliary neurotrophic factor prevents retrograde neuronal cell death in the adult nervous system. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2222-2226
11. Covas D.T., Panepucci R.A., Fontes A.M., Silva Jr. W.A., Orellana M.D., Freitas M.C., Neder L., Santos A.R., Peres L.C., Jamur M.C., and Zago M.A. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp. Hematol. 36 (2008) 642-654
12. Curtis R., Adryan K.M., Zhu Y., Harkness P.J., Lindsay R.M., and DiStefano P.S. Retrograde axonal transport of ciliary neurotrophic factor is increased by peripheral nerve injury. Nature 365 (1993) 253-255
13. D'Souza S.D., Alinauskas K.A., and Antel J.P. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J. Neurosci. Res. 43 (1996) 289-298
14. Emerich D.F., Winn S.R., Hantraye P.M., Peschanski M., Chen E.Y., Chu Y., McDermott P., Baetge E.E., and Kordower J.H. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 386 (1997) 395-399
15. Emerich D., Winn S., and Hantraye P. Dose-dependent neurochemical and functional protection afforded by encapsulated CNTF-producing cells. Cell Transplant 13 (2004) 839-844
16. Escartin C., Brouillet E., Gubellini P., Trioulier Y., Jacquard C., Smadja C., Knott G.W., Kerkerian-Le Goff L., Déglon N., Hantraye P., and Bonvento G. Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo. J. Neurosci. 26 (2006) 5978-5989
17. Follenzi A., Ailles L.E., Bakovic S., Geuna M., and Naldini L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25 (2000) 217-222
18. Gauthier R., Joly S., and Pernet V. Brain-derived neurotrophic factor gene delivery to muller glial preserves structure and function of light-damaged photoreceptors. Invest. Ophthalmol. Vis. Sci. 46 (2005) 3383-3392
19. Giess R., Mäurer M., Linker R., Gold R., Warmuth-Metz M., Toyka K.V., Sendtner M., and Rieckmann P. Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. Arch, Neurol. 59 (2002) 407-409
20. Hein M., Ernst M., Möller F., and Regensburger D. Gene transfer into rat heart-derived endothelial cells. Eur. J. Cardiothorac. Surg. 13 (1998) 460-466
21. Horita Y., Honmou O., Harada K., Houkin K., Hamada H., and Kocsis J.D. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J. Neurosci. Res. 84 (2006) 1495-1504
22. Ip N.Y., and Yancopoulos G. The neurotrophins and CNTF two families of collaborative neurotrophic factors. Annu. Rev. Neurosci. 19 (1996) 491-515
23. Jing Z., Yi L., and Jieli C. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice, too. Exp. Neurol. 195 (2005) 16-26
24. Kornek B., Storch M.K., Weissert R., Wallstroem E., Stefferl A., Olsson T., Linington C., Schmidbauer M., and Lassmann H. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157 (2000) 267-276
25. Kuhlmann T., Remington L., and Cognet I. Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis. Am. J. Pathol. 169 (2006) 584-598
26. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M.E., Remberger M., Dini G., Egeler R.M., Bacigalupo A., Fibbe W., and Ringdén O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
27. Linker R.A., Mäurer M., Gaupp S., Martini R., Holtmann B., Giess R., Rieckmann P., Lassmann H., Toyka K.V., Sendtner M., and Gold R. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 8 (2002) 620-6244
28. Lu P., Jones L.L., and Tuszynski M.H. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp. Neurol. 191 (2005) 344-360
29. Maier K., Rau C.R., Storch M.K., Sättler M.B., Demmer I., Weissert R., Taheri N., Kuhnert A.V., Bähr M., and Diem R. Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats. Brain Pathol. 14 (2004) 378-387
30. Mayer M., Bhakoo K.K., and Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes. Development 120 (1994) 143-153
31. Mitsumoto H., Ikeda K., and Klinkosz B. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BNF. Science 265 (1994) 1107-1110
32. Mondal D., Pradhan L., and LaRussa V.F. Signal transduction pathways involved in the lineage-differentiation of NSCs: can the knowledge gained from blood be used in the brain?. Cancer Invest. 22 (2004) 925-943
33. Sendtner M., Kreutzberg G.W., and Thoenen H. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345 (1990) 440-441
34. Sendtner M., Schmalbruch H., Stockli K., et al. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuropathy. Nature 358 (1992) 502-504
35. Sleeman M., Anderson K., and Lambert P. The ciliary neurotrophic factor and its receptor. Pharm. Acta Helv. 74 (2000) 265-272
36. Stankoff B., Aigrot M.S., and Noel F. Ciliary neurotrophic factor (CNTF) enhances myelin formationa novel role for CNTF and CNTF-related molecules. J. Neurosci. 22 (2002) 9221-9227
37. Stöckli K.A., Lottspeich F., Sendtner M., Masiakowski P., Carroll P., Götz R., Lindholm D., and Thoenen H. Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor. Nature 342 (1989) 920-923
38. Stöckli K.A., Lillien L.E., Näher-Noé M., Breitfeld G., Hughes R.A., Raff M.C., Thoenen H., and Sendtner M. Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain. J. Cell Biol. 115 (1991) 447-459
39. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., and Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106 (2005) 1755-1761
40. Zheng X., Hu X., Zhou G., Lu Z., Qiu W., Bao J., and Dai Y. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. J. Neuroimmunol. 194 (2008) 107-114